Church & Dwight (CHD)
Markets household and personal-care brands led by ARM & HAMMER, OXICLEAN, and THERABREATH.
Something off on this page? Send us feedback.
Sells household, personal-care, and over-the-counter products through a portfolio led by ARM & HAMMER, OXICLEAN, THERABREATH, WATERPIK, HERO, BATISTE, and TOUCHLAND, alongside a smaller specialty-products operation. The U.S. consumer business supplies most revenue, and major retailers—especially Walmart—concentrate distribution.
Develops and markets household and personal-care products across Consumer Domestic and Consumer International, led by ARM & HAMMER, OXICLEAN, THERABREATH, WATERPIK, HERO, BATISTE, TOUCHLAND, TROJAN, and FIRST RESPONSE. ARM & HAMMER spans laundry, cat litter, oral care, deodorizing, and baking soda, while the wider portfolio covers cleaning, oral care, skin and hair care, sexual health, home testing, and over-the-counter remedies.
Extends established brands into adjacent products, supports them with marketing and product innovation, and periodically adds or exits brands; recent moves added Touchland and Miss Mouth's while removing vitamin brands and selected smaller lines. Consumer Domestic supplies most sales, Consumer International serves subsidiary markets and export channels, and Specialty Products Division sells animal nutrition, specialty chemicals, and commercial and professional products. Sales remain concentrated among large retailers, with Walmart the largest customer.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 3, 2026 | RBC Capital | Reiterate | Rating: —Target: $114 | Target: $115 |
| Aug 3, 2026 | Morgan Stanley | Target | Target: $105 | Target: $112 |
| Aug 3, 2026 | Cowen & Co. | Reiterate | Rating: —Target: — | Target: $97 |
| Aug 3, 2026 | UBS | Reiterate | Rating: —Target: $100 | Target: $107 |
| Aug 3, 2026 | Jefferies | Reiterate | Rating: —Target: $102 | Target: $115 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $254.8M · Total debt $2.43B · Total assets $9.11B · Shareholders' equity $4.35B
- Revenue
- $1.53B
- Operating income
- $276.4M
- Net income
- $202.8M
HistoryDividendAnnual yield
| Institutions | 92.89% | 220.33M shares | |
|---|---|---|---|
| 1,083 holders · as of Jun 30, 2026 | |||
| Insiders | 0.09% | 220.8K shares | |
| 27 holders · as of Sep 3, 2026 | |||
| Other | 7.02% | 16.65M shares | |
| remainder | |||
237.20M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 9.46% | 22.45M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.54% | 15.51M | as of Jun 30, 2026 |
State Street CorpInstitution | 5.92% | 14.05M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 5.55% | 13.16M | as of Jun 30, 2026 |
JPMorgan Chase & CoInstitution | 3.85% | 9.14M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 26, 2026 | Carlos G. Linares | officer: EVP Chief Tech&Global New Prod | −15,375 | $103.00 |
| Aug 25, 2026 | Rene Hemsey | officer: EVP, Chief HR Officer | −5,000 | $102.26 |
| Aug 24, 2026 | Carlos G. Linares | officer: EVP Chief Tech&Global New Prod | −15,375 | $102.00 |
| Aug 11, 2026 | Bradley C. Irwin | director | −4,300 | $102.69 |
| Aug 5, 2026 | Arthur B. Winkleblack | director | −13,200 | $102.83 |
- Procter & Gamble
Broadest overlap in fabric care, home care, oral care, and grooming
- Clorox
Direct household, laundry-additive, disinfecting, and litter rival
- Colgate-Palmolive
Concentrated pressure in oral care, personal care, and home care
- Kenvue
Consumer-health and personal-care overlap across oral, OTC, and skin
- Haleon (ADR)
Oral-health and OTC-health rival with global consumer-health scale
- Unilever (ADR)
Personal-care and international home-care pressure
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Church & Dwight | $95.89 | −0.24% | $22.78B | 31.0 | 24.6 | 3.7 | +1.6% |
| Procter & Gamble | $147.42 | −0.54% | $352.35B | 22.4 | 21.1 | 4.0 | +1.5% |
| Clorox | $85.13 | −2.32% | $10.54B | 18.1 | 14.7 | 1.6 | −2.0% |
| Colgate-Palmolive | $86.33 | −0.83% | $69.66B | 34.5 | 22.0 | 3.3 | +4.9% |
| Kenvue | $17.72 | −0.81% | $34.29B | 20.5 | 14.9 | 2.2 | +3.0% |
| Haleon (ADR) | $9.16 | −0.97% | $40.74B | 19.3 | — | 2.7 | +3.7% |
| Unilever (ADR) | $62.11 | −1.31% | $135.57B | 21.5 | — | 2.6 | −17.9% |
| Median | 21.0 | 18.0 | 2.7 | +2.3% |